California dreamin' 'bout endothelin: emerging new therapeutics

Author： Warner T.D.   Elliott J.D.   Ohlstein E.H.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.17, Iss.5, 1996-05, pp. : 177-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging therapeutics for diabetic retinopathy: potential therapies for the new millennium

By Jacot J.L.   Sredy J.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 2, 1999-06 ,pp. : 307-335

Informa Healthcare

Access to resources Recommend Favorite

Emerging Developments in RNA Therapeutics

By Read Martin L   Farrow Paul J   Seymour Leonard W  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 2, 2003-04 ,pp. : 299-303

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapeutics for primary peritoneal cancer

By Slomovitz Brian M   Worley Michael J   Markman Maurie   Coleman Robert L  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 1, 2011-03 ,pp. : 71-84

Informa Healthcare

Access to resources Recommend Favorite

Emerging Peptide Therapeutics for Inflammatory Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 4, 2006-08 ,pp. : 241-246

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelin-converting enzyme inhibitors and their potential for cardiovascular and renal therapeutics

By Doggrell Sheila A  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 655-665

Informa Healthcare

Access to resources Recommend Favorite